Rxivist logo

Author: William C. Gruber

  • Most recently observed institution: Vaccine Research and Development, Pfizer Inc, Pearl River, NY

Rankings

  • All-time downloads: 328,830 (rank: 88 (tie) )
  • Categories:
    • infectious diseases: 328,830 (rank: 49 (tie) )

Downloads per author, site-wide

Preprints

Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine

infectious diseases more details view paper
  • Downloaded 180,260 times
  • Download rankings, all-time:
    • Site-wide: 24
    • In infectious diseases: 10
  • Year to date:
    • Site-wide: 4
  • Since beginning of last month:
    • Site-wide: 8

RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study

infectious diseases more details view paper
  • Downloaded 77,363 times
  • Download rankings, all-time:
    • Site-wide: 86
    • In infectious diseases: 31
  • Year to date:
    • Site-wide: 106
  • Since beginning of last month:
    • Site-wide: 108

Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report

infectious diseases more details view paper
  • Downloaded 71,207 times
  • Download rankings, all-time:
    • Site-wide: 96
    • In infectious diseases: 37
  • Year to date:
    • Site-wide: 339
  • Since beginning of last month:
    • Site-wide: 587

PanLingua

News